November marks Diabetic Eye Disease Awareness Month, highlighting the silent vision risks of diabetes and the importance of ...

Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to ...

Pediatric Eye Specialists, a North Texas-based ophthalmology practice dedicated to pediatric vision care, has published a new educational article, “Vision-Related Learning Problems,” addressing one of ...

"I was told there was no reversing my condition, that I would need lifelong treatment, and that everything I knew about ...

As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light ...

Dr Gupta said special efforts were being made to ensure quality treatment at no cost, adding that the initiative will ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of high-dose Eylea despite outstanding manufacturing concerns.

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

Gad, O.S. and Marshood, A. (2025) Bilateral Autoimmune Multifocal Choroiditis Following COVID-19 Vaccination. Open Journal of ...

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...

It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...